Skip to main content
 https://www.esot.org
logo
Login to the platform
Home
  • Courses
  • Events
    • ITS 2023
    • ESOT Action Day 2022
    • ESOT Congress
    • TLJ
      • ESOT TLJ 2.0
      • ESOT TLJ 3.0
    • 2nd ECTORS Meeting
    • VANGUARD workshop
  • Resources
    • Case Study Discussions
      • Heart Transplantation
      • Liver Transplantation
      • Paediatric Transplantation
      • Kidney Transplantation
    • Course on Supporting coherence and adaptation after transplantation
    • E-books
    • Transplant Bites
    • Webinars
    • Workshops
    • Xenotalks
  • Industry content
    • Industry-sponsored symposia @ESOT congress
    • Industry-sponsored webinars and educational materials
    • Industry corners
  • Podcasts
    • YPT series
    • History of transplantation
  • INTRODUCTION
  • MODULE 1
  • MODULE 2
  • MODULE 3
  • EVALUATION SURVEY
  • SUPPORTERS
  • INTRODUCTION

    Welcome to The Science of ECP in Solid Organ Transplantation course

    Around 25% of organ transplant recipients encounter acute rejection within the initial year post-transplantation. Acute rejection is further categorised into cellular (ACR) and antibody-mediated (AMR) forms. Over the long term, the threat shifts to chronic rejection, posing a risk to graft function and patient survival. Finding a balance between the beneficial and adverse effects of immunosuppression in preventing or treating rejection is challenging. Factors such as opportunistic infections and malignancies contribute to this challenge. Consequently, there is a keen interest in therapies that can effectively modulate alloimmune responses without suppressing immune responses to infection or malignancy. Extracorporeal Photopheresis (ECP) presents a potential for this approach in organ transplantation, yet its precise mechanism of action is still to be determined.

    Learning objectives:

    After finalising this course, participants will be able:

    • To provide an overview of the role of ECP in solid organ transplantation and why understanding its MoA is important clinically
    • To review the latest understanding on its MoA and how this is being used to treat transplant recipients in different clinical scenarios.


    The course is accessible to everyone - Physicians, Scientists, Allied Health Care Professionals, Nurses, Patients - however, to receive a certificate of attendance, you need to be an ESOT member and logged into your Transplant Live account. Not an ESOT Member? Please visit the ESOT website to learn more.


    Programme

    Lecture title Speaker’s details
    Module 1: Introduction to the Process of Immunomodulation and the Impact on Life Julie Guest
    Module 2: Biology – How does ECP work and what is the scientific rationale Andrew Gennery
    Module 3: The Science of ECP in Solid Organ Transplantation programme: Heart Transplantation Markus J. Barten
    Module 3: The Science of ECP in Solid Organ Transplantation programme: LungTransplantation Andrew Fisher
    Module 3: The Science of ECP in Solid Organ Transplantation programme: Kidney Transplantation Teresa Rampino
    MODULE 1►
    Back
    Skip Copyright Notice
    Copyright Notice
    This website and its content is copyright of ESOT - © European Society for Organ Transplantation 2014-2024. All rights reserved. 


    Skip ESOT
    ESOT

    The European Society for Organ Transplantation (ESOT) is dedicated to the pursuit of excellence in organ transplantation. Our mission is to improve outcomes for patients with terminal organ disease by means of transplantation, organ regeneration and substitution.

    Skip ESOT Headquarters
    ESOT Headquarters
    Westerdoksdijk 423, 
    1013 BX Amsterdam,
    The Netherlands

      +39 348 2786092

      askme@esot.org

      www.esot.org

    You are currently using guest access (Log in)